Dedicated to design & manufacturing for medical device
25-27 September 2019 | Shanghai,China
2018.11.13 Another Chance for Medtronic’s Renal Denervation Therapy
The Dublin-based company has received FDA approval to begin a clinical trial to evaluate the Symplicity Spyral renal denervation system with patients on medication for high blood pressure.
2018.09.12 Medtronic Is an Example of Why Diversity Matters
Medtronic has been ranked third on the 2018 Thomson Reuters Diversity and Inclusion Index, jumping ten spots from number 13, which it held in 2016 and 2017.
2018.09.04 An Australian Startup's Unique Approach to Imaging Lung Function
4Dx has developed an algorithm-based software that converts X-ray images into more detailed airflow studies.
2018.08.16 Is IBM Really Making Progress with Watson in Healthcare?
IBM's senior VP of cognitive solutions and IBM research defended the company's progress on bringing the benefits of AI to healthcare after recent media reports cast a negative light on the technology.
2018.06.25 Senseonics Wins Nod for Implantable Long-Term CGM
Senseonics Holdings said it has received a PMA for the Eversense Continous Glucose Monitoring (CGM) system. The Germantown, Md-based company said the system is the first and only CGM to feature an implantable glucose sensor and provide long-term continuous monitoring for up to three months.
2018.06.07 Medtronic Recalls HeartWare VADs Again Due to an Electrical Problem
The Class I recall includes 204,017 HeartWare devices, but the likelihood of the problem causing a serious adverse event in a patient is very low.
2018.02.28 Dexcom Shows It Can Still Hang With Abbott
Dexcom beats Wall Street expectations in earnings despite mounting pressures from Abbott's Freestyle Libre and shifting diabetes market.
2018.02.20 Medtronic is Making the Most of Value-Based Care
Medical device companies of all sizes have embraced value-based healthcare in recent years, and one of the industry's top companies is now beginning to see its value-based care programs pay off.
2018.02.11 Abbott Expands Portfolio of MRI-Ready Devices
FDA gave MR-conditional labeling to two of Abbott's cardiac rhythm management (CRM) devices, a move that further boosts the company's ability to compete with its peers in the space.
2017.11.10 DDL Expands Testing Portfolio to Support Combination Products
Mechanical and chemical testing are needed to bring complex drug-delivery products and other combination products to market.